The GID Ubiquitin Ligase and the Pro/N-End Rule Pathway in Yeast and Mammals

酵母和哺乳动物中的 GID 泛素连接酶和 Pro/N 端规则途径

基本信息

项目摘要

Project Summary/Abstract Regulated proteolysis by the ubiquitin-proteasome system (ubiquitin system) plays essential roles in a multitude of biological processes and has major ramifications for human health and disease, including illnesses that range from cancer and neurodegeneration to cardiovascular syndromes and defects of immunity. Our studies of the ubiquitin-proteasome system and the ubiquitin-dependent N-end rule pathway over the last three decades were made possible, to a large extent, by the present grant (DK039520-30), currently in its 31st year of support. The N-end rule pathway recognizes proteins containing N-terminal degradation signals called N-degrons, polyubiquitylates these proteins and thereby causes their degradation by the proteasome. Recognition components of the N-end rule pathway are called N-recognins. In eukaryotes, N-recognins are E3 ubiquitin ligases that can target N-degrons. The eukaryotic N-end rule pathway consists of three branches. The first branch, called the Arg/N-end rule pathway, targets specific unacetylated N-terminal residues of protein substrates. This branch, discovered by our laboratory in 1986, continues to be a fount of biological insights. The second branch, called the Ac/N-end rule pathway, was discovered by our laboratory in 2010. This pathway recognizes proteins that bear N-terminally acetylated residues. The third branch of the N-end rule pathway, termed the Pro/N-end rule pathway, has emerged through unpublished studies, over the last two years, by our laboratory. This proteolytic pathway is mediated by the previously known ubiquitin ligase called GID and recognizes the N-terminal proline (Pro) residue of a protein and an adjoining sequence motif. The present (DK039520) renewal application focuses on these (latest) advances and the largely unexplored Pro/N-end rule pathway, in both yeast and mammals. Its biological functions include the regulation of physiologically important transitions between cellular states that require de novo synthesis of glucose (for example, starvation or semi-starvation states) and conditions of ample glucose availability. The Pro/N-end rule pathway has other functions as well, which are beginning to emerge, in part through our recent identification of non-gluconeogenic proteins that are either targeted by or interact with the Pro/N-end rule pathway, in both yeast and mammals. These and related yeast and mammalian studies, described in Specific Aims of the present renewal application, will advance the understanding of protein degradation and the universally present N-end rule pathway.
项目摘要/摘要 泛素 - 蛋白酶体系统(泛素系统)调节的蛋白水解在 多种生物学过程,对人类健康和疾病有重大影响,包括 从癌症和神经退行性变化到心血管综合征的疾病 免疫。我们对泛素 - 蛋白酶体系统和泛素依赖性的N端规则途径的研究 在过去的三十年中 目前正在获得支持的第31年。 N端规则途径识别含有N末端的蛋白质 降解信号称为n-脱果龙,polyupiquityLeS trices prits这些蛋白质,从而导致它们 蛋白酶体降解。 n端规则途径的识别成分称为n-识别剂。 在真核生物中,n-识别素是可以靶向N-脱绿素的E3泛素连接酶。真核生物N端规则 途径由三个分支组成。第一个分支称为arg/n-end规则途径,针对特定 蛋白质底物的非乙酰化N末端残基。这个分支,由我们的实验室发现,1986年, 仍然是生物学见解的源泉。第二个分支称为AC/N-END规则途径,是 我们的实验室在2010年发现。该途径识别含有N末端乙酰化的蛋白质 残留物。 N-End规则途径的第三个分支称为Pro/N-End规则途径,已经出现 通过未发表的研究,在过去的两年中,我们的实验室。这种蛋白水解途径是 由先前已知的泛素连接酶介导的,称为GID并识别N末端脯氨酸(Pro) 蛋白质的残基和相邻的序列基序。 目前(DK039520)续订申请侧重于这些(最新)的进步,并且很大程度上 在酵母和哺乳动物中均未探索的Pro/N-End规则途径。它的生物功能包括 调节在需要从头综合的细胞状态之间生理上重要的过渡 葡萄糖(例如,饥饿或半饥饿状态)和充足的葡萄糖可用性条件。这 Pro/n-End规则途径也具有其他功能,这些功能已开始出现 最近鉴定出由Pro/N-End靶向或相互作用的非葡萄糖蛋白 在酵母和哺乳动物中,统治途径。这些以及相关的酵母和哺乳动物研究 当前续签应用的具体目的,将提高对蛋白质降解的理解和 普遍呈现的n端规则途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALEXANDER J VARSHAVSKY其他文献

ALEXANDER J VARSHAVSKY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALEXANDER J VARSHAVSKY', 18)}}的其他基金

Ubiquitin Ligases, Mechanisms and Functions of the N-End Rule Pathway
N 端规则通路的泛素连接、机制和功能
  • 批准号:
    7996378
  • 财政年份:
    2009
  • 资助金额:
    $ 61.77万
  • 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
  • 批准号:
    7513269
  • 财政年份:
    2008
  • 资助金额:
    $ 61.77万
  • 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
  • 批准号:
    8118431
  • 财政年份:
    2008
  • 资助金额:
    $ 61.77万
  • 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
  • 批准号:
    7661504
  • 财政年份:
    2008
  • 资助金额:
    $ 61.77万
  • 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
  • 批准号:
    7871450
  • 财政年份:
    2008
  • 资助金额:
    $ 61.77万
  • 项目类别:
MULTITARGET DRUGS: VERIFICATION-OF-PRINCIPLE STUDIES
多靶点药物:原理验证研究
  • 批准号:
    6033211
  • 财政年份:
    2000
  • 资助金额:
    $ 61.77万
  • 项目类别:
MULTITARGET DRUGS: VERIFICATION-OF-PRINCIPLE STUDIES
多靶点药物:原理验证研究
  • 批准号:
    6342202
  • 财政年份:
    2000
  • 资助金额:
    $ 61.77万
  • 项目类别:
MECHANICS AND FUNCTIONS OF THE N-END RULE PATHWAY
N 端规则路径的机制和功能
  • 批准号:
    7007642
  • 财政年份:
    1995
  • 资助金额:
    $ 61.77万
  • 项目类别:
The GID Ubiquitin Ligase and the Pro/N-End Rule Pathway in Yeast and Mammals
酵母和哺乳动物中的 GID 泛素连接酶和 Pro/N 端规则通路
  • 批准号:
    10202561
  • 财政年份:
    1995
  • 资助金额:
    $ 61.77万
  • 项目类别:
The Mammalian Arg/N-End Rule Pathway: Substrates, Functions, and Mechanisms
哺乳动物 Arg/N 端规则途径:底物、功能和机制
  • 批准号:
    8601698
  • 财政年份:
    1995
  • 资助金额:
    $ 61.77万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bacterial sialometabolic activity impacts periodontal immunity and microbiota
细菌唾液酸代谢活动影响牙周免疫和微生物群
  • 批准号:
    10520050
  • 财政年份:
    2020
  • 资助金额:
    $ 61.77万
  • 项目类别:
Bacterial sialometabolic activity impacts periodontal immunity and microbiota
细菌唾液酸代谢活动影响牙周免疫和微生物群
  • 批准号:
    10310503
  • 财政年份:
    2020
  • 资助金额:
    $ 61.77万
  • 项目类别:
Molecular Neuropharmacology and Signaling of Histone H2A.Z
组蛋白 H2A.Z 的分子神经药理学和信号转导
  • 批准号:
    9626431
  • 财政年份:
    2017
  • 资助金额:
    $ 61.77万
  • 项目类别:
Molecular Neuropharmacology and Signaling of Histone H2A.Z
组蛋白 H2A.Z 的分子神经药理学和信号转导
  • 批准号:
    9480880
  • 财政年份:
    2017
  • 资助金额:
    $ 61.77万
  • 项目类别:
Molecular Neuropharmacology and Signaling of Histone H2A.Z
组蛋白 H2A.Z 的分子神经药理学和信号转导
  • 批准号:
    10115117
  • 财政年份:
    2017
  • 资助金额:
    $ 61.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了